2019
DOI: 10.3390/ijerph16020196
|View full text |Cite
|
Sign up to set email alerts
|

Adherence to Treatment in Stroke Patients

Abstract: Background: Compliance with medication in patients who have suffered stroke is usually not-optimal. This study aims to measure the level of compliance with the treatment and to identify socio-demographic, clinical, and subjective factors related to the long-term compliance of stroke patients with their treatment. Methods: 140 patients (66.4% males) suffered an ischemic stroke at least six months old, participated in the survey. Compliance was measured using the Medication Adherence Report Scale and the quality… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
43
0
7

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(51 citation statements)
references
References 42 publications
1
43
0
7
Order By: Relevance
“…The result of the present study revealed that there is significant correlation between total adherence scores and total self-efficacy score at post phase. Cheiloudaki & Alexopoulos, (2019) supported these findings showed significant correlation between adherance with therapies and their total self-efficacy score at post phase. Wolf et al, (2017), also found that there is a significant correlation between their adherence with therapies and stroke self-efficacy score.…”
Section: Discussionsupporting
confidence: 64%
“…The result of the present study revealed that there is significant correlation between total adherence scores and total self-efficacy score at post phase. Cheiloudaki & Alexopoulos, (2019) supported these findings showed significant correlation between adherance with therapies and their total self-efficacy score at post phase. Wolf et al, (2017), also found that there is a significant correlation between their adherence with therapies and stroke self-efficacy score.…”
Section: Discussionsupporting
confidence: 64%
“…In addition, it can be explained as a vascular alteration that acutely or intermittently weakens blood flow in the brain, caused by arterial obstruction (ischemic stroke) or its rupture (hemorrhagic stroke) [3]. The clinical signs are directly related to the location and extent where the injury occurred [4].…”
Section: Introductionmentioning
confidence: 99%
“…The Barriers-to-Treatment Model (1997) is one of the few comprehensive frameworks that can be used to detect both relevant context determinants of adherence, additionally to individual characteristics. This model is still valid today, because evidence points out the importance of life events (Martinez et al, 2018), support of the close environment (Cheiloudaki & Alexopoulos, 2019;Cook, Schmiege, Bradley-Springer, Starr, & Carrington, 2018), and relevance of beliefs, attitudes, self-efficacy, and motivation (Cook et al, 2018;Matsuzawa et al, 2019). When barriers add up, treatment gains are becoming too limited in comparison to the effort, which might lead to nonadherence because of (a) practical obstacles (e.g., time constraints), (b) treatment demands (e.g., frequency of sessions), (c) perceived relevance issues (e.g., doubts on usefulness), (d) problems in the therapeutic relationship (e.g., limited contact), and (e) stressful events (e.g., parental divorce; .…”
Section: Introductionmentioning
confidence: 99%
“…Adherence is a crucial parameter of treatment success, considering there is evidence for a direct association between high adherence and better clinical outcomes (Candler et al, 2018;Matsuzawa et al, 2019). It is recognized as a general threat in several nonpharmacological chronic disease interventions (Cheiloudaki & Alexopoulos, 2019;Dunbar-Jacob & Mortimer-Stephens, 2001).…”
Section: Introductionmentioning
confidence: 99%